Xinjie Chen Selected Research

Xinjie Chen Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 10/2008
4	Esophageal Squamous Cell Carcinoma 10/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2024 - 02/2021
3	Melanoma (Melanoma, Malignant) 11/2022 - 04/2022
2	Inflammation (Inflammations) 01/2024 - 01/2021
2	Neuroinflammatory Diseases 01/2024 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 06/2019
2	Esophageal Neoplasms (Esophageal Cancer) 10/2023 - 01/2020
2	Thalassemia 01/2012 - 11/2011
1	Infections 01/2024
1	Multiple Sclerosis 01/2024
1	COVID-19 01/2024
1	Vesicular Stomatitis 10/2023
1	Lung Neoplasms (Lung Cancer) 11/2022
1	Stomach Neoplasms (Stomach Cancer) 11/2022
1	Osteonecrosis (Kienbock's Disease) 04/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Infarction (Infarctions) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Dysbiosis 01/2022
1	Mycoses (Diseases, Fungus) 01/2021
1	Osteoarthritis 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Abscess 01/2021
1	Cerebral Hemorrhage 11/2019
1	Leukemia 06/2019
1	1.35-Mb Chromosome 1q21.1 Deletion Syndrome 04/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012

Drug/Important Bio-Agent (IBA)

3	NanovaccinesIBA 11/2022 - 04/2022
2	CytokinesIBA 01/2024 - 10/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2008
2	EnzymesIBA 01/2023 - 01/2023
2	VaccinesIBA 11/2022 - 04/2022
2	Peptides (Polypeptides)IBA 11/2022 - 11/2022
2	MagnesiumIBA 11/2022 - 11/2022
2	AntigensIBA 11/2022 - 10/2008
2	MicroRNAs (MicroRNA)IBA 04/2022 - 11/2019
2	Messenger RNA (mRNA)IBA 04/2015 - 10/2008
1	Carisoprodol (Soma)FDA LinkGeneric 01/2024
1	Tyrosine (L-Tyrosine)FDA Link 11/2023
1	Collagen Type I (Type I Collagen)IBA 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	CollagenIBA 10/2023
1	Histocompatibility Antigens Class IIBA 10/2023
1	Small Interfering RNA (siRNA)IBA 10/2023
1	I-antigenIBA 10/2023
1	Glycoproteins (Glycoprotein)IBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	magnetoferritinIBA 01/2023
1	Arsenic Trioxide (Trisenox)FDA Link 01/2023
1	Drug CarriersIBA 01/2023
1	Glucose OxidaseIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	EpitopesIBA 11/2022
1	Imiquimod (Aldara)FDA LinkGeneric 11/2022
1	Cancer VaccinesIBA 11/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2022
1	auristatinIBA 11/2022
1	Thrombin FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	PropionatesIBA 01/2022
1	CholesterolIBA 01/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	GadoliniumIBA 01/2022
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022
1	SolventsIBA 02/2021
1	Albumin-Bound Paclitaxel FDA Link 02/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2021
1	GelatinIBA 01/2021
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2021
1	oridoninIBA 06/2019
1	HomoharringtonineIBA 06/2019
1	Glia Maturation Factor (GMF)IBA 01/2018
1	Cre recombinaseIBA 01/2012
1	Doxycycline (Periostat)FDA LinkGeneric 01/2012
1	Histone Deacetylase InhibitorsIBA 11/2011
1	theasinensin AIBA 11/2011

Therapy/Procedure

7	Therapeutics 01/2024 - 01/2012
4	Radiotherapy 10/2023 - 01/2020
3	Drug Therapy (Chemotherapy) 11/2022 - 02/2021
2	Immunotherapy 10/2023 - 11/2022
2	Lasers (Laser) 01/2023 - 01/2021
2	Chemoradiotherapy 11/2022 - 01/2022
1	Intravenous Administration 10/2023
1	Subcutaneous Injections 11/2022
1	Neoadjuvant Therapy 01/2020
1	Adjuvant Radiotherapy 01/2020